The Effects of the L / N‐Type Calcium Channel Blocker (Cilnidipine) on Sympathetic Hyperactive Morning Hypertension: Results From ACHIEVE‐ONE

The Ambulatory Blood Pressure Control and Home Blood Pressure (Morning and Evening) Lowering By N‐Channel Blocker Cilnidipine (ACHIEVE‐ONE) trial is a large‐scale clinical study on blood pressure (BP) and pulse rate (PR) in the real world with use of cilnidipine, a unique L/N‐type Ca channel blocker...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Hypertens (Greenwich)
Main Authors: Kario, Kazuomi, Ando, Shin‐ichi, Kido, Hidenori, Nariyama, Jin, Takiuchi, Shin, Yagi, Tetsuo, Shimizu, Toshiki, Eguchi, Kazuo, Ohno, Minoru, Kinoshita, Osamu, Yamada, Takahisa
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2012
Assuntos:
Original Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8034443/
https://ncbi.nlm.nih.gov/pubmed/23339732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados